Patrick F. Grealish

Statistics

Publications

Citations

231

H-Index

Active since

1998

Affiliations

Eli Lilly (United States)(Current)

Patrick F. Grealish is an author at Eli Lilly (United States) specializing in inflammatory signaling, clinical pharmacology, and ejection fraction pharmacology.

Publications per year

1998–2023

Publications

Interleukin (IL)-1 Receptor–associated Kinase (IRAK) Requirement for Optimal Induction of Multiple IL-1 Signaling Pathways and IL-6 Production

Palanisamy Kanakaraj, Peter Schäfer, Druie Cavender et al. · The Journal of Experimental Medicine · 1998 · 193 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Development of a long‐acting relaxin analogue, LY3540378, for treatment of chronic heart failure

Petra Verdino, Stacey L. Lee, Fariba N. Cooper et al. · British Journal of Pharmacology · 2023 · 27 citations · Full text

Medicine, Cardiology, Pharmacology +14

Long‐Duration and Non‐Invasive Photoacoustic Imaging of Multiple Anatomical Structures in a Live Mouse Using a Single Contrast Agent

Anjul Khadria, Chad D. Paavola, Yang Zhang et al. · Advanced Science · 2022 · 11 citations · Full text

Engineering, Anatomy, Bioengineering +14

1–3 of 3